<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-106346</identifier>
<setSpec>0210-573X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Objectives: The purpose of this study was to examine the relationship between diagnosis of atypical endometrial hyperplasia in a curettage sample and the &amp;#64257;nal pathological result after hysterectomy. Material and methods: There were 33 patients who ful&amp;#64257;lled the criteria for inclusion in this study. Clinical records were reviewed to identify clinical, histopathological and treatment data. Results: Adenocarcinoma was found in four (12.12%) of the 33 surgical specimens from hysterectomy. Endometrial hyperplasia was found in 28 specimens, although 12 (36.3%) of these specimens showed no atypia. No endometrial hyperplasia or signs of any other tumor were found in one specimen Conclusions: After pathological &amp;#64257;ndings of atypical endometrial hyperplasia, the next step should be to perform hysterectomy. Given the major risks of delaying or not performing surgery for a possible concomitant endometrial cancer, which can be treated and cured, the risk of overtreating some patients is acceptable (AU)</dc:description>
<dc:creator>Valenzuela, P</dc:creator>
<dc:creator>Guzmán, M</dc:creator>
<dc:creator>Heron, S</dc:creator>
<dc:creator>Martínez-Parrondo, N</dc:creator>
<dc:creator>Zapico, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivos: El propósito de este estudio ha sido examinar la relación entre el diagnóstico de hiperplasia atípica en el legrado o biopsia endometrial y el resultado definitivo en la pieza de histerectomía. Material y método Se encontraron 33 pacientes que cumplían las condiciones del estudio y revisamos las historias para conocer los datos clínicos, anatomopatológicos y terapéuticos relevantes. Resultados Se observó adenocarcinoma en 4 (12,12%) de las 33 piezas de histerectomía, se encontró hiperplasia en 28 de las piezas, aunque en 12 de ellas sin atipia (36,36%) y no se halló hiperplasia ni tumor en una de ellas. Conclusiones El paso siguiente a un diagnóstico de hiperplasia endometrial atípica por biopsia debe ser la histerectomía, asumiendo el sobre tratamiento que supone para algunas pacientes dado el importante riesgo de retrasar u obviar la cirugía de un cáncer coincidente operable y curable (AU)</dc:description>
<dc:source>Clín. investig. ginecol. obstet. (Ed. impr.);39(5): 196-198, sept.-oct. 2012.</dc:source>
<dc:identifier>ibc-106346</dc:identifier>
<dc:title xml:lang="es">Hiperplasia endometrial atípica en biopsia preoperatoria y resultado de la pieza de histerectomía</dc:title>
<dc:subject>^d4793^s22053</dc:subject>
<dc:subject>^d7225^s22074</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d38338^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d31595^s22053</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>201210</dc:date>
</metadata>
</record>
</ibecs-document>
